Altered molecular signature of the intestinal microbiota in irritable bowel syndrome patients versus healthy controls: An updated systematic review.

Irritable bowel syndrome (IBS) affects millions of people worldwide, causing uncomfortable digestive symptoms like diarrhea, constipation, bloating, and abdominal pain. Researchers have been investigating whether the balance of bacteria living in our intestines might play a role in IBS symptoms. This comprehensive review analyzed 44 studies comparing the gut bacteria of IBS patients to healthy individuals. The researchers found that people with IBS have less diversity in their gut bacteria and show specific imbalances depending on their symptoms. Those with diarrhea-predominant IBS had lower levels of certain beneficial bacteria like Butyricimonas, while those with constipation-predominant IBS showed decreased Firmicutes and Actinobacteria bacteria, along with increases in other bacterial types. These bacterial imbalances were found throughout the digestive tract, from the small intestine to the colon. For patients considering acupuncture for IBS, these findings are relevant because traditional Chinese medicine has long recognized the importance of digestive balance. Acupuncture may help regulate digestive function and reduce IBS symptoms through multiple pathways, potentially including effects on gut motility, inflammation, and the gut-brain connection. While this study focused on the bacterial composition of the gut rather than acupuncture specifically, understanding that IBS involves measurable changes in gut bacteria reinforces the value of integrative approaches that address the whole digestive system. If you're considering acupuncture for IBS symptoms, seek a licensed acupuncturist with experience treating digestive disorders.

This systematic review analyzed 44 case-control studies examining fecal and colonic microbiota composition in IBS patients versus healthy controls, searching PubMed, EMBASE, and Web of Science databases through December 2024. Key findings demonstrated significantly reduced intestinal microbiome diversity in IBS patients with characteristic phylum-level dysbiosis involving Firmicutes and Bacteroidetes imbalances. IBS-D patients exhibited decreased Butyricimonas and Proteobacteria, while IBS-C patients showed reduced Firmicutes and Actinobacteria with increased Verrucomicrobiota and Proteobacteria. Microbial disruptions were identified throughout the gastrointestinal tract including duodenum, jejunum, colon, and rectum. Clinical takeaway: The confirmed gut dysbiosis in IBS patients supports microbiota as a therapeutic target, which may inform acupuncture treatment strategies. Practitioners should consider these subtype-specific microbial patterns when formulating individualized treatment protocols, particularly when combining acupuncture with dietary recommendations or probiotic adjunct therapies. Further research is needed to establish whether acupuncture's clinical effects in IBS involve modulation of the gut microbiome.